Research Article: Pharmacogenomic Analysis of CYPA* and Tacrolimus Trough Concentrations in Vietnamese Renal Transplant Outcomes
Introduction:
Tacrolimus (Tac) is the most used immunosuppressive medication to prevent acute rejection following renal transplantation. It has a narrow therapeutic index and its pharmacokinetics (PK) exhibits high inter- and intra-individual variability. Therefore, therapeutic drug monitoring (TDM) of Tac has been implemented regularly to maintain efficacy and minimize side effects. In Vietnam, the initial dose of Tac is adjusted exclusively based on the patient’s weight. Subsequently, therapeutic drug monitoring for…
Read more